Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Cancer Treatment Reviews|February 15, 2011
Evolving options for the treatment of metastatic breast cancer: progression-free survival as an endpointSara A HurvitzTherapeutic Advances in Medical Oncology|September 4, 2012
The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studiesSara A Hurvitz, Reva KakkarClinical Breast Cancer|August 2, 2021
Can Women With HER2-Positive Metastatic Breast Cancer Be Cured?Farnaz Haji, Sara A HurvitzBreast Cancer (Dove Medical Press)|December 25, 2013
Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancerSara A Hurvitz, Reva KakkarJournal of Neuro-Oncology|January 29, 2014
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancerParvin F Peddi, Sara A HurvitzJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2026
Current Management of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in a Changing LandscapeMarla Lipsyc-Sharf, Sara A HurvitzExpert Opinion on Biological Therapy|June 15, 2005
Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavIdSara A Hurvitz, John M TimmermanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2025
TOP1 Priority: Advancing Biomarker-Driven Patient Selection for the Use of ADCsWilliam R Gwin, Sara A HurvitzCurrent Opinion in Obstetrics & Gynecology|October 23, 2020
Innovations in targeted therapies for triple negative breast cancerKelly E McCann, Sara A HurvitzBreast Cancer Research and Treatment|April 11, 2020
Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancerPamela R Drullinsky, Sara A HurvitzPageof 14